The Effect of Stevioside on Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease
Journal of Agricultural and Food Chemistry · 2026
DOI: 10.1021/acs.jafc.6c05606 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, 2026. Verfasst von Changfa Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Clinical Epidemiology and Methodology (CCEM), The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou51…. Hauptthemen laut MEDLINE: Diterpenes, Kaurane, Glucosides, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province, Young Top Talent Project in Special Support Plan for Training High-level Talents in Guangdong.
Abstract (Originalsprache)
Stevioside is a widely used natural non-nutritive sweetener derived from Stevia rebaudiana; however, its effects on MASLD and the underlying molecular mechanisms remain unclear. This study aimed to elucidate the effects and mechanisms of stevioside on MASLD, based on the high-fat diet-induced mice model and palmitic acid-treated hepatocyte model. We found that stevioside significantly alleviated hepatic steatosis in MASLD mice and reduced plasma ALT and AST levels and hepatic triglyceride and total cholesterol. In palmitic acid-induced hepatocytes, stevioside significantly reduced intracellular lipid droplet content and upregulated the protein levels of p-AMPK, PPARα, and EHHADH. Pharmacological inhibition of AMPK and PPARα revealed that stevioside regulated PPARα expression and downstream EHHADH expression in an AMPK-dependent manner. To conclude, stevioside significantly improved hepatic steatosis in MASLD by activating the AMPK/PPARα/EHHADH pathway, potentially generating novel evidence to help control the escalating disease burden of MASLD from the perspective of natural sweetener.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Clinical Epidemiology and Methodology (CCEM), The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou510317, China.
- Department of Infectious Diseases, The Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou510317, China.
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou510006, China.
- School of Public Health, Guangdong Pharmaceutical University, Guangzhou510310, China.
- Department of Endocrinology, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou510170, China.
- Father Sean O'Sullivan Research Centre, St. Joseph's Healthcare Hamilton, McMaster University, HamiltonL8N 4A6Canada.
ORCID-Profile: Guowei Li
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Young Top Talent Project in Special Support Plan for Training High-level Talents in Guangdong
- Science Foundation of Guangdong Second Provincial General Hospital
Zitieren
APA
Zhang, C., Li, W., Li, K., Wang, R., Kang, L., Peng, M., & Li, G. (2026). The Effect of Stevioside on Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Agricultural and Food Chemistry. https://doi.org/10.1021/acs.jafc.6c05606
Vancouver
Zhang C, Li W, Li K, Wang R, Kang L, Peng M, et al. The Effect of Stevioside on Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Agricultural and Food Chemistry. 2026. doi:10.1021/acs.jafc.6c05606
BibTeX
@article{Zhang2026,
author = {Zhang, Changfa and Li, Wenli and Li, Kangjun and Wang, Ruoting and Kang, Lili and Peng, Miaoguan and Li, Guowei},
title = {The Effect of Stevioside on Hepatic Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
doi = {10.1021/acs.jafc.6c05606}
}
EUVIMED